首页> 外文学位 >Phenanthropiperidine alkaloids: Methodology development, synthesis and biological evaluation.
【24h】

Phenanthropiperidine alkaloids: Methodology development, synthesis and biological evaluation.

机译:蒽哌啶生物碱:方法学的发展,合成和生物学评估。

获取原文
获取原文并翻译 | 示例

摘要

The phenanthropiperidines are remarkably potent anti-proliferative alkaloids. Only one member of this class has been tested in the clinic, but the trials were terminated shortly thereafter due to adverse neurological side-effects. This work is directed towards the development of safe phenanthropiperidines for the treatment of cancer. It focuses on synthetic methodologies that facilitate their preparation and biological studies to better understand their neurological effects.The preparation of cyclic enaminones in high enantiomeric purity is made possible through a one-flask, two-step protocol that uses mild Boc-deprotection conditions to suppress racemization. This reaction enables the preparation of monocyclic and bicyclic, six- and seven-membered enaminones, some of which can be used as precursors to phenanthropiperidine alkaloids.Elaboration of the enaminone scaffold was made possible with a direct palladium(II)-catalyzed arylation using aryltrifluoroborates as coupling partners. Combined with the enaminone methodology this approach gives rapid access to enantiomerically pure 3-arylpiperidines. The utility of these scaffolds were demonstrated in the synthesis of two natural products: (+)-ipalbidine and (+)-antofine.A short and high-yielding synthetic route has also been devised to provide tylocrebrine, the only phenanthropiperidine to enter clinical trials. We report the first enantioselective synthesis of tylocrebrine which uses a novel aryl-alkene oxidative coupling reaction that surmounts the historical challenge of obtaining a single phenanthrene regioisomer. A small collection of tylocrebrine analogs were prepared and studied along with tylocrebrine to elucidate the cause of tylocrebrine's neurological side-effects. Although the causes remain elusive, tylocrebrine and several of its analogs were found to bind to key biogenic amine receptors, disclosing another potential risk factor for their therapeutic use. The phenanthrene substitution pattern, however, had an marked influence on binding and could be used to minimize these off-target interactions.
机译:苯并哌啶是非常有效的抗增殖生物碱。该类别中只有一名成员在临床中接受过测试,但是由于不良的神经系统副作用,此后不久就终止了该试验。这项工作的目的是开发用于治疗癌症的安全苯哌啶。它着重于有助于其制备和生物学研究以更好地了解其神经学作用的合成方法学。通过使用温和的Boc脱保护条件抑制反应的一瓶两步操作,可以制备高对映体纯度的环状烯胺酮外消旋化。该反应能够制备单环和双环的六元和七元烯胺酮,其中一些可用作苯并哌啶生物碱的前体。使用芳基三氟硼酸酯的直接钯(II)催化芳基化可以制备烯胺骨架。作为耦合伙伴。结合烯胺酮方法,该方法可快速获得对映体纯的3-芳基哌啶。这些支架的实用性在两种天然产物(+)-依帕立定和(+)-antofine的合成中得到了证明。还设计了一种短而高产的合成途径来提供酪氨素,这是唯一进入临床试验的苯并哌啶。我们报告了首次使用新的芳基-烯烃氧化偶合反应的酪胺醇对映选择性合成,该反应克服了获得单个菲区域异构体的历史挑战。制备了少量的酪氨酰脑类似物,并与酪氨酰脑素一起研究,以阐明酪氨酰脑素的神经系统副作用的原因。尽管原因仍然难以捉摸,但发现酪氨蛋白及其一些类似物与关键的生物胺受体结合,从而揭示了其治疗用途的另一个潜在危险因素。然而,菲取代模式对结合有显着影响,可用于使这些脱靶相互作用最小化。

著录项

  • 作者

    Niphakis, Micah James.;

  • 作者单位

    University of Kansas.;

  • 授予单位 University of Kansas.;
  • 学科 Chemistry Organic.Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 376 p.
  • 总页数 376
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号